BioPlus appoints chief strategic officer

ALTAMONTE SPRINGS, Fla. — A former MedfusionRx VP has joined BioPlus as its new chief strategic officer.

In his new role, Russell Gay will provide key leadership for all of the business development at BioPlus, including the strengthening and growth of relationships with payers, physicians, the pharmaceutical industry and various industry partners, BioPlus said.

Gay is an industry veteran with 25 years in the healthcare industry. While serving as MedFusionRx VP, he played a significant role in building that company into one of the largest specialty pharmacies in the United States.

“Russell is tasked with developing and diversifying our business. He shares our values, understands the intricacies of the specialty infusion market, and appreciates our unique position of leading measurable outcomes,” said Stephen Vogt, BioPlus president and CEO. “Russell’s business experience in the key areas of infusion, home care and specialty have prepared him well to lead our business development.”